Merck Analysts Slash Their Forecasts After Q2 Results

Benzinga19minutes ago

Merck Is Maintained at Buy by B of A Securities

Dow Jones13:34 ET

Merck Price Target Cut to $145.00/Share From $150.00 by B of A Securities

Dow Jones13:34 ET · Ratings

UBS Maintains Buy on Merck & Co, Lowers Price Target to $142

BenzingaJul 31 11:46 ET · Ratings

Merck & Co Analyst Ratings

BenzingaJul 31 11:45 ET · Ratings

Analyzing Merck & Co In Comparison To Competitors In Pharmaceuticals Industry

BenzingaJul 31 11:00 ET